OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Perspectives on how to build bridges between regulation, health technology assessment and clinical guideline development: a qualitative focus group study with European experts
Milou A. Hogervorst, Mathias Møllebæk, Rick A. Vreman, et al.
BMJ Open (2023) Vol. 13, Iss. 8, pp. e072309-e072309
Open Access | Times Cited: 12
Milou A. Hogervorst, Mathias Møllebæk, Rick A. Vreman, et al.
BMJ Open (2023) Vol. 13, Iss. 8, pp. e072309-e072309
Open Access | Times Cited: 12
Showing 12 citing articles:
Multiple Perspectives on the Need for Real‐World Evidence to Inform Regulatory and Health Technology Assessment Decision‐Making: Scoping Review and Stakeholder Interviews
Marieke S. Jansen, Olaf M. Dekkers, Saskia le Cessie, et al.
Pharmacoepidemiology and Drug Safety (2025) Vol. 34, Iss. 1
Open Access
Marieke S. Jansen, Olaf M. Dekkers, Saskia le Cessie, et al.
Pharmacoepidemiology and Drug Safety (2025) Vol. 34, Iss. 1
Open Access
Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy
Elaine Julian, Tom Belleman, Maria João Garcia, et al.
Journal of Market Access & Health Policy (2025) Vol. 13, Iss. 1, pp. 6-6
Open Access
Elaine Julian, Tom Belleman, Maria João Garcia, et al.
Journal of Market Access & Health Policy (2025) Vol. 13, Iss. 1, pp. 6-6
Open Access
Patient-Relevance of Outcome Measures in Breast Cancer Clinical Trials: A Cross-Sectional Comparative Analysis of Patient Preferences and Trials Conducted Between 2014 and 2024
J.M. Plooij, Diana Delnoij
Expert Review of Pharmacoeconomics & Outcomes Research (2025)
Open Access
J.M. Plooij, Diana Delnoij
Expert Review of Pharmacoeconomics & Outcomes Research (2025)
Open Access
Stakeholders’ Perspectives Toward the Use of Patient Registry Data for Decision-Making on Medicines: A Cross-Sectional Survey
Fabian Windfuhr, Sieta T. de Vries, Maria Melinder, et al.
Drug Safety (2025)
Open Access
Fabian Windfuhr, Sieta T. de Vries, Maria Melinder, et al.
Drug Safety (2025)
Open Access
Evolving Recommendations for Patient Populations Among Oncology Medicines: A Quantitative and Qualitative Analysis
Milou A. Hogervorst, Rick A. Vreman, Theresa Oduol, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access
Milou A. Hogervorst, Rick A. Vreman, Theresa Oduol, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access
HTA Between Theory And Practice: Exploring Boundary Work In Broadening HTA For MedTech Governance
Renée Else Michels, Diana Maria Johanna Delnoij, Martinus Bertram de Graaff
Health Policy and Technology (2025), pp. 101008-101008
Open Access
Renée Else Michels, Diana Maria Johanna Delnoij, Martinus Bertram de Graaff
Health Policy and Technology (2025), pp. 101008-101008
Open Access
Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy
Francine Brinkhuis, Elaine Julian, Hendrika van den Ham, et al.
Health Research Policy and Systems (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Francine Brinkhuis, Elaine Julian, Hendrika van den Ham, et al.
Health Research Policy and Systems (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Analytical Methods for Comparing Uncontrolled Trials with External Controls from Real-World Data: a Systematic Literature Review and Comparison to European Regulatory and Health Technology Assessment Practice
Milou A. Hogervorst, Kanaka V Soman, Helga Gardarsdóttir, et al.
Value in Health (2024)
Open Access | Times Cited: 3
Milou A. Hogervorst, Kanaka V Soman, Helga Gardarsdóttir, et al.
Value in Health (2024)
Open Access | Times Cited: 3
Healthcare decision-making for tumour-agnostic therapies in Europe: lessons learned
Milou A. Hogervorst, Christine C. van Hattem, Gabe S. Sonke, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104031-104031
Open Access | Times Cited: 2
Milou A. Hogervorst, Christine C. van Hattem, Gabe S. Sonke, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104031-104031
Open Access | Times Cited: 2
Getting ready for the European Health Data Space (EHDS): IDERHA's plan to align with the latest EHDS requirements for the secondary use of health data
Rada Hussein, Irina Balaur, Anja Burmann, et al.
Open Research Europe (2024) Vol. 4, pp. 160-160
Open Access | Times Cited: 1
Rada Hussein, Irina Balaur, Anja Burmann, et al.
Open Research Europe (2024) Vol. 4, pp. 160-160
Open Access | Times Cited: 1
Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value?
Lourens T. Bloem, Hubert G.M. Leufkens, Sophie E Berends, et al.
Drug Discovery Today (2024), pp. 104251-104251
Open Access | Times Cited: 1
Lourens T. Bloem, Hubert G.M. Leufkens, Sophie E Berends, et al.
Drug Discovery Today (2024), pp. 104251-104251
Open Access | Times Cited: 1
Getting Ready for the European Health Data Space (Ehds): The Iderha's Plan to Align with the Ehds Requirements for the Secondary Use of Health Data
Rada Hussein, Irina Balaur, Anja Burmann, et al.
(2024)
Closed Access
Rada Hussein, Irina Balaur, Anja Burmann, et al.
(2024)
Closed Access
The arisal of data spaces: why I am excited and worried
Liesbet M. Peeters
Frontiers in Immunology (2024) Vol. 15
Open Access
Liesbet M. Peeters
Frontiers in Immunology (2024) Vol. 15
Open Access
The Critical Intersect of Regulations, Health Technology Assessment, and Drug Safety Assessments
Wenwen Yang, Yi‐Chen Juan, Grace Hui‐Min Wu, et al.
Drug Safety (2023) Vol. 47, Iss. 4, pp. 289-299
Closed Access
Wenwen Yang, Yi‐Chen Juan, Grace Hui‐Min Wu, et al.
Drug Safety (2023) Vol. 47, Iss. 4, pp. 289-299
Closed Access
